NANOMUSE, LLC
Next-generation nanomedicine for acute ischemic stroke
Next-generation nanomedicine for acute ischemic stroke is a funding opportunity from NANOMUSE, LLC, up to 351461, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
ABSTRACT / PROJECT SUMMARY Acute ischemic stroke is poised for a revolution. With the advent of mechanical thrombectomy in the last decade, the worst clots can be removed. While thrombectomy has improved outcomes, most treated patients still have severe deficits, in large part due to secondary injury caused by…